vaxgen, inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of biologic products for the prevention and treatment of human infectious disease. vaxgen is currently developing next-generation vaccines against anthrax, smallpox, and meningitis b.

Vaxgen Biodefense Biopharmaceutical Biologic Anthrax Smallpox Bioterrorism Us Biodefense Biopharmaceutical Company Biopharmaceutical Companies Biopharmaceuticals Vaccine Vaccines

Homeland Security Biodefense Vaccines Biodefense Company Bioterror Countermeasures Biochemical Recombinant Technology Biologics Contract Manufacturing Biologic Manufacturer Pre-exposure Prophylaxis Post-exposure Prophylaxis Next-generation Anthrax Vaccine Meningitis Meningitis B

Contact:	650-624-1000
Address:	1000 Marina Blvd #200 Brisbane, California   94005-1841 , USA
Url:	http://www.vaxgen.com
Fax:	650-624-1001
Year Established:	1995
Annual Sales:	US$10 Million - US$50 Million
Business Type:	Manufacturer